Drug Shortage Report for SANDOZ ESOMEPRAZOLE
| Report ID | 251562 |
| Drug Identification Number | 02460939 |
| Brand name | SANDOZ ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100GRT |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-03 |
| Estimated end date | 2025-03-21 |
| Actual end date | 2025-03-24 |
| Shortage status | Resolved |
| Updated date | 2025-03-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-03-25 | English | Compare |
| v5 | 2025-03-24 | French | Compare |
| v4 | 2025-03-24 | English | Compare |
| v3 | 2025-03-04 | English | Compare |
| v2 | 2025-03-03 | French | Compare |
| v1 | 2025-03-03 | English | Compare |
Showing 1 to 6 of 6